Obesity

New England Journal of Medicine

Volumn 337, Issue 6, 1997, Pages 396-407

  Rosenbaum, Michael ^a   Leibel, Rudolph L ^a   Hirsch, Jules ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY WEIGHT; CALCULATION; CALORIC INTAKE; ENERGY EXPENDITURE; HEALTH CARE COST; MORBIDITY; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; SITTING; WEIGHT REDUCTION;

ENERGY INTAKE; ENERGY METABOLISM; FEEDING BEHAVIOR; HOMEOSTASIS; HUMANS; OBESITY; WEIGHT LOSS;

EID: 0030820723     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199708073370606     Document Type: Review

References (140)

1. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults, JAMA 1994;272:205-11.
2. Long-term pharmacotherapy in the management of obesity: National Task Force on the Prevention and Treatment of Obesity. JAMA 1996;276: 1907-15.
3. Wadden TA. Treatment of obesity by moderate and severe caloric restriction: results of clinical research trials. Ann Intern Med 1993;229:688-93.
4. Rosenbaum M, Leibel RL. Pathophysiology of childhood obesity. Adv Pediatr 1988;35:73-137.
5. Bouchard C, ed. Genetics of obesity. Boca Raton, Fla.: CRC Press, 1994.
6. Van Itallie T. Health implications of overweight and obesity in the United States. Ann Intern Med 1985;103:983-8.
7. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994;74:761-811.
8. Must A, Jacques PF, Dalla GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents: a follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992;327:1350-5.
9. Brownell KD, Fairburn CG, eds. Eating disorders and obesity: a comprehensive handbook. New York: Guilford Press, 1995.
10. Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R, eds. Progress in obesity research: 7. London: John Libbey, 1996.
11. Bouchard C, Bray GA, eds. Regulation of body weight: biological and behavioral mechanisms. Vol. 7. West Sussex, England: John Wiley, 1996.
12. Cahill GF Jr. Starvation in man. N Engl J Med 1970;282:668-75.
13. Belanger B, Cupples L, D'Agostino R. The Framingham Study: an epidemiologic study investigation of cardiovascular disease. Section 36. Measures at each examination and interexamination consistency of specified characteristics. Washington, D.C.: Government Printing Office, 1988. (Framingham publication no. 88-2970.)
14. Flier JS. The adipocyte: storage depot or node on the energy information superhighway? Cell 1995;80:15-8.
15. Figlewicz DP, Schwartz MW, Seeley RJ, et al. Endocrine regulation of food intake and body weight. J Lab Clin Med 1996;127:328-32.
16. Rohner-Jeanrenaud F. A neuroendocrine reappraisal of the dual-centre hypothesis: its implications for obesity and insulin resistance. Int J Obes Relat Metab Disord 1995;19:517-34.
17. Friedman MI, Tordoff MG, Ramirez I. Integrated metabolic control of food intake. Brain Res Bull 1986;17:855-9.
18. Geary N. Role of gut peptides in meal regulation. In: Weston LA, Savage LM, eds. Obesity: advances in understanding and treatment. Southborough, Mass.: International Business Communications, 1996:2.1.1.-2.1.34.
19. Edholm OG. Energy balance in man carried out by the Division of Human Physiology, National Institute for Medical Research. J Hum Nutr 1977;31:413-31.
20. Birch LL, Johnson SL, Andresen G, Peters JC, Schulte MC. The variability of young children's energy intake. N Engl J Med 1991;324:232-5.
21. Flatt JP. Dietary fat, carbohydrate balance, and weight maintenance. Ann N Y Acad Sci 1993;683:122-40.
22. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond B Biol Sci 1953;140:578-96.
23. Hirsch J. Discussion. Adv Psychosom Med 1972;7:229-42.
24. Leibel RL, Berry EM, Hirsch J. Metabolic and hemodynamic responses to endogenous and exogenous catecholamines in formerly obese subjects. Am J Physiol 1991;260:R785-R791.
25. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995;332:621-8. [Erratum, N Engl J Med 1995;333:399.]
26. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995;332:621-8. [Erratum, N Engl J Med 1995;333:399.]
27. Landsberg L, Young JB. The role of the sympathoadrenal system in modulating energy expenditure. Clin Endocrinol Metab 1984;13:475-99.
28. Danforth E Jr, Burger A. The role of thyroid hormones in the control of energy expenditure. Clin Endocrinol Metab 1984;13:581-95.
29. Brownell KD, Fairburn CG, eds. Eating disorders and obesity: a comprehensive handbook. New York: Guilford Press, 1995.
30. Spina M, Merlo-Pich E, Chan RK, et al. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 1996;273:1561-4.
31. Arone LJ, Mackintosh R, Rosenbaum M, Leibel RL, Hirsch J. Autonomic nervous system activity and energy expenditure during weight gain and weight loss. Am J Physiol 1995;269:R222-R225.
32. Butera PC, Bradway DM, Cataldo NJ. Modulation of the satiety effect of cholecystokinin by estradiol. Physiol Behav 1993;53:1235-8.
33. Woods SC, Chavez M, Park CR, et al. The evaluation of insulin as a metabolic signal influencing behavior via the brain. Neurosci Biobehav Rev 1996;20:139-44.
34. Bray GA. Nutrient intake is modulated by peripheral peptide administration. Obes Res 1995;3:Suppl 4:569S-572S.
35. Corbett SW, Keesey RE. Energy balance of rats with lateral hypothalamic lesions. Am J Physiol 1982;242:E273-E279.
36. Steffens AB, Strubbe JH, Balkan B, Scheurink FW. Neuroendocrine mechanisms involved in regulation of body weight, food intake and metabolism. Neurosci Biobehav Rev 1990;14:305-13.
37. Leibowitz SF. Brain peptides and obesity: pharmacologic treatment. Obes Res 1995;3:Suppl 4:573S-589S.
38. Harris RB. Role of set-point theory in regulation of body weight. FASEB J 1990;4:3310-8.
39. Flatt JP. Use and storage of carbohydrate and fat. Am J Clin Nutr 1995:61 Suppl:952S-959S.
40. Jebb SA, Goldberg GR, Coward WA, Murgatroyd PR, Prentice AM. Effects of weight cycling caused by intermittent dieting on metabolic rate and body composition in obese women. Int J Obes 1991;15:367-74.
41. Hill JO, Drougas H, Peters JC. Obesity treatment: can diet composition play a role? Ann Intern Med 1994;119:694-7.
42. Leibel RL, Hirsch J, Appel BE, Checani GC. Energy intake required to maintain body weight is not affected by wide variation in diet composition. Am J Clin Nutr 1992;55:350-5.
43. Weigle DS, Sande KJ, Iverius PH, Monsen ER, Brunzell JD. Weight loss leads to a marked decrease in nonresting energy expenditure in ambulatory human subjects. Metabolism 1988;37:930-6.
44. Leibel RL, Hirsch J. Diminished energy requirements in reduced-obese patients. Metabolism 1984;33:164-70.
45. Krotkiewski M, Grimby G, Holm G, Szczepanik J. Increased muscle dynamic endurance associated with weight reduction on a very-low-calorie diet. Am J Clin Nutr 1990;51:321-30.
46. Leibel RL, Chua SC Jr, Chung WK. Animal models of genetic obesity. In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R, eds. Progress in obesity research: 7. London: John Libbey, 1996:263-71.
47. Ravussin E, Lillioja S, Knowler WC, et al. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988;318: 467-72.
48. Roberts SB, Savage J, Coward WA, Chew B, Lucas A. Energy expenditure and intake in infants born to lean and overweight mothers. N Engl J Med 1988;318:461-6.
49. Astrup A, Buemann B, Christensen NJ, Toubro S. Failure to increase lipid oxidation in response to increasing dietary fat content in formerly obese women. Am J Physiol 1994;266:E592-E599.
50. Ravussin E. Metabolic differences and the development of obesity. Metabolism 1995;44:Suppl 3:12-4.
51. Newsholme EA. Substrate cycles: their metabolic, energetic, and thermic consequences in man. Biochem Soc Symp 1978;43:183-205.
52. Wolfe RR. Assessment of substrate cycling in humans using tracer methodology. In: Kinney JM, Tucker HN, eds. Energy metabolism: tissue determinants and cellular corollaries. New York: Raven Press, 1992:495-523.
53. Himms-Hagen J. Brown adipose tissue thermogenesis and obesity. Prog Lipid Res 1989;28:67-115.
54. Trayhurn P, Nicholls D, eds. Brown adipose tissue. Baltimore: Edward Arnold, 1986.
55. Fleury CJ, Neverova M, Collins S, et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 1997;15: 269-72.
56. Flier JS, Lowell BB. Obesity research springs a proton leak. Nat Genet 1997;15:223-4.
57. Hirsch J. Obesity: some heat but not enough light. Nature 1997;387: 27-8.
58. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 1992; 13:387-414.
59. Chua SC Jr, White DW, Wu-Peng XS, et al. Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr). Diabetes 1996;45: 1141-3.
60. Morley JE. Neuropeptide regulation of appetite and weight. Endocr Rev 1987;8:256-87.
61. Smith GP, Jerome C, Norgren R. Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats. Am J Physiol 1985;249: R638-R643.
62. Oldendorf WH. Blood-brain barrier permeability to peptides: pitfalls in measurement. Peptides 1981;2:Suppl 2:109-11.
63. Maddison S. Intraperitoneal and intracranial cholecystokinin depress operant responding for food. Physiol Behav 1977;19:819-24.
64. Blundell J. Pharmacological approaches to appetite suppression. Trends Pharmacol Sci 1991;12:147-57.
65. Bray GA, York DA, Fisler JS. Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system. Vitam Horm 1989;45:1125.
66. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32. [Erratum, Nature 1995;374:479.]
67. Schwartz MW, Baskin DG, Bukowski TR, et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996;45:531-5.
68. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-6.
69. Pelleymounter MA, Cullen M, Baker MJ, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269:540-3.
70. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-9.
71. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature 1996;380:677
72. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-2.
73. Chehab FH, Mounzih K, Lu R, Lim ME. Early onset of reproductive function in normal female mice treated with leptin. Science 1997;275:88-90.
74. Kolaczynski JW, Nyce MR, Considine RV, et al. Acute and chronic effccts of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 1996;45:699-701.
75. Rentsch J, Chiesci M. Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett 1996;379:55-9.
76. Murakami T, Iida M, Shima K. Dexamethasone regulates obese gene expression in isolated rat adipocytes. Biochem Biophys Res Commun 1995;214:1260-7.
77. Rosenbaum M, Nicolson M, Hirsch J, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996;81:3424-7.
78. Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996;381:415 21.
79. Clement K, Garner C, Hager J, et al. Indication for linkage of the human OB gene region with extreme obesity. Diabetes 1996;45:687-90.
80. Reed DR, Ding Y, Xu W, Cather C, Green ED, Price RA. Extreme obesity may be linked to markers flanking the human OB gene. Diabetes 1996;45:691-4.
81. Duggirala R, Stern MP, Mitchell BD, et al. Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7. Am J Hum Genet 1996;59:694-703.
82. Norman RA, Leibel RL, Chung WK, et al. Absence of linkage of obesity and energy metabolism to markers flanking homologues of rodent obesity genes in Pima Indians. Diabetes 1996;45:1229-32.
83. Considine RV, Considine EL, Williams CJ, et al. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 1995;95:2986-8.
84. Considine RV, Considine EL, Williams CJ, et al. Mutation screening and identification of a sequence variation in the human ob gene coding region. Biochem Biophys Res Commun 1996;220:735-9.
85. Hamilton BS, Paglia D, Kwan AY, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1995;1:953-6.
86. Klein S, Coppack SW, Mohamed-Ali V, Landt M. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996;45: 984-7.
87. McGregor GP, Desaga JF, Ehlenz K, et al. Radioimmunologic measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology 1996;137:1501-4.
88. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996;274:1185-8.
89. Caro JF, Kolaczynski JW, Nyce MR, et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996;348:159-61.
90. Sinha MK, Opentanova I, Ohannesian JP, et al. Evidence of free and bound leptin in human circulation: studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996;98:1277-82.
91. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996;81:3419-23.
92. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
93. Rosenbaum M, Nicolson M, Hirsch J, Murphy E, Chu F, Leibel RL. Effects of weight change or plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab (in press).
94. Kolaczynski JW, Ohannesian JP, Considine RV, Marco CC, Caro JF. Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab 1996;81:4162-5.
95. Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL, Stern JS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab 1996;81:4406-13.
96. Ostlund RE Jr, Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 1996;81:3909-13.
97. Tartanlia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor. OB-R. Cell 1995;83:1263-71.
98. Chua SC Jr, Chung WK, Wu-Peng XS, et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996;271:994-6.
99. Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632-5.
100. Frankish HM, Dryden S, Hopkins D, Wang Q, Williams G. Neuropeptide Y, the hypothalamus, and diabetes: insights into the central control of metabolism. Peptides 1995;16:757-71.
101. Zukowska-Grojec Z. Neuropeptide Y: a novel sympathetic stress hormone and more. Ann N Y Acad Sci 1995;771:219-33.
102. Schwartz MW, Figlewicz DP, Woods SC, Porte D Jr, Baskin DG. Insulin, neuropeptide Y, and food intake. Ann N Y Acad Sci 1993;692:60-71.
103. Chua SC Jr, Brown AW, Kim J, Hennessey KL, Leibel RL, Hirsch J. Food deprivation and hypothalamic neuropeptide gene expression: effects of strain background and the diabetes mutation. Brain Res Mol Brain Res 1991;11:291-9.
104. Billington CJ, Briggs JE, Harker S, Grace M, Levine AS. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol 1994;266:R1765-R1770.
105. Frisch RE, McArthur JW. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 1974;185:949-51.
106. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962;14:353-62.
107. Prevalence of overweight among adolescents - United States, 1988-91. MMWR Morb Mortal Wkly Rep 1994;43:818-21.
108. Leibel R, Bahary N, Friedman J. Genetic variation and nutrition in obesity. In: Simopoulos A, Childs B, eds. Genetic variation and nutrition. Basel, Switzerland: Karger, 1990:90-101.
109. Stunkard AJ, Sørensen TIA, Hanis C, et al. An adoption study of human obesity. N Engl J Med 1986;314:193-8.
110. Bouchard C. Genetics of obesity: an update on molecular markers. Int J Obes Relat Metab Disord 1995;19:Suppl 3:S10-S13.
111. Reed DR, Ding Y, Xu W, et al. Human obesity does not segregate with the chromosomal regions of Prader-Willi, Bardet Biedl, Cohen, Borjeson, or Wilson-Turner syndromes. Im J Obes Relat Metab Disord 1995; 19:599-603.
112. Chagnon YC, Pérusse L, Lamothe M, et al. Suggestive linkages between markers on human 1p32-p22 and body fat and insulin levels in the Quebec Family Study. Obes Res 1997;5:115-21.
113. Thompson DB, Janssen RC, Ossowski VM, Prochazka M, Knowler WC, Bogardus C. Evidence for linkage between a region on chromosome 1p and the acute insulin response in Pima Indians. Diabetes 1995;44:478-81.
114. Chung WK, Power-Kehoe L, Chua M, Leibel RL. Mapping of the OB receptor to 1p in a region of nonconserved gene order from mouse and rat to human. Genome Res 1996;6:431-8.
115. Considine RV, Considine EL, Williams CJ, Hyde TM, Caro JF. The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the ob/ob mouse and fa/fa rat mutations. Diabetes 1996;45:992-4.
116. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-8.
117. Fricker LD, Berman YL, Leiter EH, Devi LA. Carboxypeptidase E activity is deficient in mice with the fat mutation: effect on peptide processing. J Biol Chem 1996;271:30619-24.
118. fat mice. Cell 1997;88:73-83.
119. Jackson RS, Creemers JWM, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohor mone convertase 1 gene. Nat Genet 1997;16:303-6.
120. Leibel RL. And finally, genes for human obesity. Nat Genet 1997;16: 218-20.
121. Schemmel R, Mickelsen O, Gill JL. Dietary obesity in rats: body weight and body fat accretion in seven strains of rats. J Nutr 1970;100: 1041-8.
122. West DB, Boozer CN, Moody DL, Atkinson RL. Dietary obesity in nine inbred mouse strains. Am J Physiol 1992;262:R1025-R1032.
123. Warden CH, Fisler JS, Shoemaker SM, et al. Identification of four chromosomal loci determining obesity in a multifactorial mouse model. J Clin Invest 1995;95:1545-52.
124. West DB, Goudey-Lefevre J, York B, Truett GE. Dietary obesity linked to genetic loci on chromosomes 9 and 15 in a polygenic mouse model. J Clin Invest 1994;94:1410-6.
125. Methods for voluntary weight loss and control: NIH Technology Assessment Conference Panel: Consensus Development Conference, 30 March to 1 April, 1992. Ann Intern Med 1993;119:764-70.
126. Lantigua RA, Amatruda JM, Biddle TL, Forbes GE, Lockwood DH. Cardiac arrhythmias associated with a liquid protein diet for the treatment of obesity. N Engl J Med 1980;303:735-8.
127. Sours HE, Frattali VP, Brand CD, et al. Sudden death associated with very low calorie weight reduction regimens. Am J Clin Nutr 1981;34:453-61.
128. Felig P. Four questions about protein diets. N Engl J Med 1978;298: 1025-6.
129. Frank GC, Berenson GS, Webber LS. Dietary studies and the relationship of diet to cardiovascular disease risk factor variables in 10-year-old children: the Bogalusa Heart Study. Am J Clin Nutr 1978;31:328-40.
130. Schaeter EJ, Lichtenstein AH, Lamon-Fava S, et al. Body weight and low-density lipoprotein cholesterol changes after consumption of a low-fat ad libitum diet. JAMA 1995;274:1450-5.
131. Sheppard L, Kristal AR, Kushi LH. Weight loss in women participating in a randomized trial of low-fat diets. Am J Clin Nutr 1991;54:821-8.
132. Tremblay A, Buemann B. Exercise-training, macronutrient balance and body weight control. Int J Obes Relat Metab Disord 1995;19:79-86.
133. Tremblay A, Simoneau JA, Bouchard C. Impact of exercise intensity on body fatness and skeletal muscle metabolism. Metabolism 1994;43: 814-8.
134. Weintraub M. Long-term weight control study: conclusions. Clin Pharmacol Ther 1992;51:642-6.
135. Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996;335: 609-16.
136. Manson JE, Faich GA. Pharmacotherapy for obesity - do the benefits outweigh the risks? N Engl J Med 1996;335:659-60.
137. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995;83:803-12.
138. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996; 271:665-8.
139. Rose C, Vargas F, Facchinetti P, et al. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase. Nature 1996;380: 403-9.
140. Gerald C, Walker MW, Criscione L, et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 1996;382:168-71.